The Kipuwex-IDE Group partnership will build on Kipuwex’s easily attachable, light weight Internet of Medical Things (IoMT) device which wirelessly and continuously measures clinically relevant biomarkers vital to the assessment of human well-being and disease management to facilitate real-time data collection, improve remote patient care, enhance clinical workflows and increase healthcare provider efficiency.

 

IDE Group’s entrepreneurial partnership will help Kipuwex develop and commercialise a differentiated telehealth offering delivering meaningful healthcare outcomes in Europe, the Asia Pacific region and globally.

 

Kipuwex and IDE Group expect to launch their innovative telehealth offering in the next two to three years.